{"name":"Noxopharm Limited","slug":"noxopharm-limited","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.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?oc=5","date":"2025-12-04","type":"pipeline","source":"simplywall.st","summary":"We Think Noxopharm (ASX:NOX) Has A Fair Chunk Of Debt - simplywall.st","headline":"We Think Noxopharm (ASX:NOX) Has A Fair Chunk Of Debt","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAJBVV95cUxQckpPUldMdjR0RTFmWjRtTWF0Mmtqc1ZoZklERVA2QzlQRk1nYlBPbmd4ZHN4SDdubElXSWhDS1Jzd0NzOFhuVEpvTjY1MzlzLWNVdV9XSE5kekFVMWV2TWxMYmZrdG5JYl9HS0dGZkpxV0JuSnJ2dUdoaDhlT3Z0Y25KbFR6aE9yb1ZzRHlDaUpTemUzM0dWMm5tX3Z5eGZjMnBKa19rMHRQaFRUWWNkMW9qS3laZTdJenBWYkxOVktoM1JFeUFrTnhWQ3NUQ0h4Z3ctdl9sai1qVjNqb2Exd1U1dlpnYkhkUzRjeS1lanVQSDVLQ2pxZE95V2tSc25Hcl9xWFU1VHFZaUhUUDM2RjR0Y19XNjVKMFFkVA?oc=5","date":"2025-11-27","type":"pipeline","source":"PR Newswire","summary":"Rhabdomyosarcoma Market is Expected to Rise Throughout Forecast Period (2025-2034) with Promising Drug Candidates in Pipeline | DelveInsight - PR Newswire","headline":"Rhabdomyosarcoma Market is Expected to Rise Throughout Forecast Period (2025-2034) with Promising Drug Candidates in Pip","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxQcmZna3FLWUNKVXlsWVlBZWxKenlFSlZRaE0xUlZLdHJOMEtjWVVvOWw5R2RzYlBJRGxRcjY3R1otR2FSREZwVkUxMFJwZGhsRjhGc3R6Mm5MOVczblF2dWIxSjZ0VDRDbTUxZVpPcy0wc0ZiZDJJWWJPSVpsMmV2SnczNW4xbjY1ZTFzTGN2TVVYTmd5X1FGbE8xUQ?oc=5","date":"2025-11-05","type":"pipeline","source":"Stockhead","summary":"ASX Health October Winners: When CSL sneezes, sector catches flu - Stockhead","headline":"ASX Health October Winners: When CSL sneezes, sector catches flu","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxOSHhQUXg2aGlzLU95bVlfcU1FTnhNbmxRaFhlSXhHOEt0TmFLT0MyWjhGMlZ3RXlVUGhrRjNEd2xDUTRBWFdtRjNNd1EwQVQybTRyejk2T2VlWUVfc1BSVzQ1MnlTam85SXBJb1RvSVBLMmFldkpuTVh6Qy04Q3Nrcm4wRW5lWVc4QlRTYkRnQXkyU19rUFRpcTRXRURpSElSeGlvRWw5NU04bzVqYUFjQ3pmQQ?oc=5","date":"2025-09-17","type":"pipeline","source":"Stockhead","summary":"Biocurious: Noxopharm has the ‘burning fire’ of inflammation squarely in its sights - Stockhead","headline":"Biocurious: Noxopharm has the ‘burning fire’ of inflammation squarely in its sights","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-07-29","type":"pipeline","source":"simplywall.st","summary":"We're Keeping An Eye On Noxopharm's (ASX:NOX) Cash Burn Rate - simplywall.st","headline":"We're Keeping An Eye On Noxopharm's (ASX:NOX) Cash Burn Rate","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4AFBVV95cUxPOTBsY2xKd1hGd1laU2Q4M3JiUUVRdVFqVGpOX19nYWF5T0ZEQ1JHRnVOOGJBTkRxQjNqMXpHMVUweXRXM2IzbGUxaWJIYVJVT0NYcjRXdG9IUl9tOHpIN01mMzlQcmhfbzU3Y2J4b1VEdjFmYVNiYW9PTHU5bnlRbTlPcEZZZXRDaS1XWDBtckgtMkcxQWlyVk9KaUJvbzJCbGxpZnc5cTQyek1DQks3V2M2N05lSFJrTVVzMmFxclU4b1VrTFo4Rm1FVjlfRGdnUUhqejI4V011MUJPSTVibA?oc=5","date":"2025-04-17","type":"pipeline","source":"PR Newswire","summary":"FYARRO Sets New Standard in Rare Oncology Market with Strong Growth Prospects | DelveInsight - PR Newswire","headline":"FYARRO Sets New Standard in Rare Oncology Market with Strong Growth Prospects | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxOalJtR2w0aVlVUFlGNlo5bEhmT1RxTmRmcm1FV1l0Z0dCQkVrSVN2aWo3dE1ERTBkR00zbzEwWUtGcjFiM2ZTc3NXeHBsbWZEYlU1Qk9QVXpvT21TMy10NlFiWnhXaTh5NXljeVJvalBmMkNBQXpfZzFUWHNJak1FLXlLZHptaGF2M2plZXQ3NjV3cjZLbmVhM3o1Q01CbXRiZFZQTm83Qlcyam93RnBJOFV4ZG9RU3cwZnJZTUhLejdNakZGbFZN?oc=5","date":"2024-10-01","type":"pipeline","source":"PR Newswire","summary":"PLK-1 Inhibitors Market to Register Immense Growth by 2034 | DelveInsight - PR Newswire","headline":"PLK-1 Inhibitors Market to Register Immense Growth by 2034 | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgJBVV95cUxNTmtpYURaVEhPYkNqc0FkczdWaHNyQXpkVXRSaVRUT0RDTm42bDQ1N1d3eDh6ZXd6czdkVGdPak5IbGxaekROMEduQnJ2LUdzMFJpbTNyVlRuVDBQMmxHbFZFTlBOS3JvbkgwMVYxSEJnenNnU0dvaF9yUDMtTmxjcXVMeWRxX1hMZ3hTcXdVdFpGM0tUYjFmdHIxbDh4OE5iTVlBQ3Q4V2JyY0g1cWpnZmdzV21yMktObTJNMmY3X2FBQ2R0aXBKbEtOOElkdS1iSnd3SGNRWHNlYzdVT3VBTkh4cklVU0dsaWF2dlhmUnZKNmRBLUplLVhpSm8tODJnNVdHVWlxQUR3U1ZIRVFxYVdPczVMSXhxOGc?oc=5","date":"2023-05-10","type":"pipeline","source":"PR Newswire","summary":"Soft Tissue Sarcoma Pipeline Space Brims With Novel Emerging Therapies with Over 125 Key Companies Working in the Domain | DelveInsight - PR Newswire","headline":"Soft Tissue Sarcoma Pipeline Space Brims With Novel Emerging Therapies with Over 125 Key Companies Working in the Domain","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxQelBqWDdza3lNaURvdHlVTDFKdEZxMmFRUFF2TWg1RmstZ09GYWllb3VYMHpuTGlqb0RoT2cxWFl5enljcFBhRVhVdXVMS2xuOWpMejRyeVM4OUJVNTNZNjVlRzdGdWU0cVJ2c003c1o2S2NZbTdxOWxaTnluc2NCMWkzbElmZGVUaWFYRUJtcVBGN0pNcFE?oc=5","date":"2023-03-28","type":"pipeline","source":"BioPharma APAC","summary":"Noxopharm Announces Novel mRNA Vaccine Enhancer - BioPharma APAC","headline":"Noxopharm Announces Novel mRNA Vaccine Enhancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZ0FVX3lxTE9HZUE5TDhSWm9KZk5Dem9RdUdPWmhzNG1Hc1NxNklqdXBZRVVOdUZfWDBCUm5senRXYUthNjl3MGdkV1JucmNsekxhbjdlNHpBRkdIdjJkVkhSelZMdzJvcjU2anFRamc?oc=5","date":"2021-07-29","type":"pipeline","source":"Yahoo Finance UK","summary":"Island Pharmaceuticals Limited (ILA.AX) balance sheet - Yahoo Finance UK","headline":"Island Pharmaceuticals Limited (ILA.AX) balance sheet","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiVEFVX3lxTE1ZN2laN2dKMk5nOVo5WXMtazhpUG1hcVNmTi1CcXJBUEY2R3FGZzFmNGlENlEzVFA3dDJiMU1ZZ2VIc29xdGFCR3VDbExaSnZhUTlPeQ?oc=5","date":"2017-05-29","type":"pipeline","source":"Yahoo Finance Australia","summary":"Noxopharm Limited (NOX.AX) stock price, news, quote and history - Yahoo Finance Australia","headline":"Noxopharm Limited (NOX.AX) stock price, news, quote and history","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxNdHVZY0lhLVJXbkJkaTFjRFNvWnpvdkFNRmNOMlJnRFNVYzhjUl80UTVPTjhMX19vbV83UmJ2MUFvakU5Y2lmendQOU9JWFBFSVhXZ1RRZkNrT3VtbkRfU1FCdzJzWXF5YlhNbjNzS1ZsYlczSmRPZ1RrZ3FSNGhKMVVaSGV2ZWNhSDlFRjA0RXFlVnR0MGpPa3E4XzVkUlhGWmRSY1dPcDg4RzQ0alEwRw?oc=5","date":"2016-06-27","type":"pipeline","source":"Fierce Pharma","summary":"Graham Kelly seeks cash for new Australia oncology biotech - Fierce Pharma","headline":"Graham Kelly seeks cash for new Australia oncology biotech","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}